Directed evolution of hyperactive integrases for site specific insertion of transgenes

Area of Science:

• Molecular Biology
• Gene Therapy
• Biotechnology

Background:

• Current gene delivery methods struggle with low efficiency and DNA breaks.
• Serine integrases offer precise DNA insertion at specific genomic sites.
• Targeting integrase attachment sites avoids double-strand DNA breaks.

Purpose of the Study:

• To improve the efficiency of large transgene delivery using serine integrases.
• To develop a directed evolution strategy for enhancing integrase activity.
• To overcome limitations of existing gene delivery technologies.

Main Methods:

• Developed IntePACE (Integrase Phage-Assisted Continuous Evolution) for rapid mutagenesis.
• Applied IntePACE to systematically improve PhiC31 and Bxb1 serine integrases.
• Combined synergistic mutations to generate hyperactive integrase variants.

Main Results:

• Achieved integration of multi-gene cargoes at rates up to 80% of target chromosomes.
• Generated novel hyperactive serine integrase mutants.
• Successfully inserted a 15.7 kb therapeutic DNA cargo encoding Von Willebrand Factor.

Conclusions:

• IntePACE significantly enhances serine integrase activity for efficient gene delivery.
• This technology accelerates the development of gene delivery therapeutics.
• The directed evolution strategy is adaptable for improving other natural integrases.